» Articles » PMID: 24512175

Accounting for Centre-effects in Multicentre Trials with a Binary Outcome - When, Why, and How?

Overview
Publisher Biomed Central
Date 2014 Feb 12
PMID 24512175
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Background: It is often desirable to account for centre-effects in the analysis of multicentre randomised trials, however it is unclear which analysis methods are best in trials with a binary outcome.

Methods: We compared the performance of four methods of analysis (fixed-effects models, random-effects models, generalised estimating equations (GEE), and Mantel-Haenszel) using a re-analysis of a previously reported randomised trial (MIST2) and a large simulation study.

Results: The re-analysis of MIST2 found that fixed-effects and Mantel-Haenszel led to many patients being dropped from the analysis due to over-stratification (up to 69% dropped for Mantel-Haenszel, and up to 33% dropped for fixed-effects). Conversely, random-effects and GEE included all patients in the analysis, however GEE did not reach convergence. Estimated treatment effects and p-values were highly variable across different analysis methods.The simulation study found that most methods of analysis performed well with a small number of centres. With a large number of centres, fixed-effects led to biased estimates and inflated type I error rates in many situations, and Mantel-Haenszel lost power compared to other analysis methods in some situations. Conversely, both random-effects and GEE gave nominal type I error rates and good power across all scenarios, and were usually as good as or better than either fixed-effects or Mantel-Haenszel. However, this was only true for GEEs with non-robust standard errors (SEs); using a robust 'sandwich' estimator led to inflated type I error rates across most scenarios.

Conclusions: With a small number of centres, we recommend the use of fixed-effects, random-effects, or GEE with non-robust SEs. Random-effects and GEE with non-robust SEs should be used with a moderate or large number of centres.

Citing Articles

Statistical methods in the analysis of multicentre HIV randomized controlled trials in the African region: a scoping review.

Mazinu M, Gwebushe N, Manda S, Reddy T BMC Med Res Methodol. 2025; 25(1):3.

PMID: 39773382 PMC: 11707912. DOI: 10.1186/s12874-024-02441-w.


Digital rehabilitation care planning for people with chronic diseases (RehaPro-SERVE): study protocol for a German multicentre randomised controlled trial.

Buch K, der Wardt V, Seifart U, Haasenritter J, Maulbecker-Armstrong C, Seferi P Trials. 2024; 25(1):728.

PMID: 39472948 PMC: 11520684. DOI: 10.1186/s13063-024-08571-2.


Efficacy of high-flow nasal oxygen therapy started in the emergency room versus conventional oxygen therapy in patients with acute hypoxaemic respiratory distress: protocol for a French multicentric, prospective, open and randomised superiority....

Pretalli J, Parmentier A, Mauny F, Desmettre T, Marjanovic N, Capellier G BMJ Open. 2024; 14(8):e083262.

PMID: 39160110 PMC: 11337659. DOI: 10.1136/bmjopen-2023-083262.


Oral resveratrol in adults with knee osteoarthritis: A randomized placebo-controlled trial (ARTHROL).

Nguyen C, Coudeyre E, Boutron I, Baron G, Daste C, Lefevre-Colau M PLoS Med. 2024; 21(8):e1004440.

PMID: 39137167 PMC: 11321588. DOI: 10.1371/journal.pmed.1004440.


Comparative effectiveness of an individualized model of hemodialysis vs conventional hemodialysis: a study protocol for a multicenter randomized controlled trial (the TwoPlus trial).

Murea M, Raimann J, Divers J, Maute H, Kovach C, Abdel-Rahman E Trials. 2024; 25(1):424.

PMID: 38943204 PMC: 11212207. DOI: 10.1186/s13063-024-08281-9.


References
1.
. ICH Harmonised Tripartite Guideline. Statistical principles for clinical trials. International Conference on Harmonisation E9 Expert Working Group. Stat Med. 1999; 18(15):1905-42. View

2.
Kahan B, Morris T . Adjusting for multiple prognostic factors in the analysis of randomised trials. BMC Med Res Methodol. 2013; 13:99. PMC: 3733981. DOI: 10.1186/1471-2288-13-99. View

3.
Kahan B, Morris T . Analysis of multicentre trials with continuous outcomes: when and how should we account for centre effects?. Stat Med. 2012; 32(7):1136-49. DOI: 10.1002/sim.5667. View

4.
Raab G, Day S, Sales J . How to select covariates to include in the analysis of a clinical trial. Control Clin Trials. 2000; 21(4):330-42. DOI: 10.1016/s0197-2456(00)00061-1. View

5.
Cook J, Bruckner T, MacLennan G, Seiler C . Clustering in surgical trials--database of intracluster correlations. Trials. 2012; 13:2. PMC: 3311136. DOI: 10.1186/1745-6215-13-2. View